Abstract
Chimeric antigen receptor T cells (CART) targeting lymphocyte antigens can induce T cell fratricide and require additional engineering to mitigate self-damage. We demonstrate that the expression of a chimeric antigen receptor (CAR) targeting CD5, a prominent pan-T cell antigen, induces rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting. Notably, exposure of healthy and malignant T cells to CD5.CART cells induces similar internalization of CD5 on target cells, transiently shielding them from cytotoxicity. However, this protection is short-lived, as sustained activity of CD5.CART cells in patients with T cell malignancies results in full ablation of CD5+ T cells while sparing healthy T cells naturally lacking CD5. These results indicate that continuous downmodulation of the target antigen in CD5.CART cells produces effective fratricide resistance without undermining their on-target cytotoxicity.
Original language | English (US) |
---|---|
Article number | 101628 |
Journal | Cell Reports Medicine |
Volume | 5 |
Issue number | 7 |
DOIs | |
State | Published - Jul 16 2024 |
Keywords
- CAR
- CD5
- chimeric antigen receptor
- clinical trials
- fratricide
- off-tumor toxicity
- T cell fratricide
- T cell malignancies
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)